subject area of

• "Clozapine makes me quite drowsy, so when I wake up in the morning those first cups of coffee are really handy" : an exploratory qualitative study of excessive caffeine consumption among individuals with schizophrenia  Academic Article
• A Mood Stabilizer With Risperidone or Haloperidol for Mania  Academic Article
• A UK consensus on the administration of aripiprazole for the treatment of mania  Academic Article
• A national survey of practice nurse involvement in mental health interventions  Academic Article
• A randomised controlled trial of acceptance and commitment therapy (ACT) for psychosis: study protocol  Academic Article
• A randomised controlled trial of acceptance-based cognitive behavioural therapy for command hallucinations in psychotic disorders  Academic Article
• A survey of patient satisfaction with and subjective experiences of treatment with antipsychotic medication  Academic Article
• Acute effects of antipsychotic drugs on cardiovascular responses to stress  Academic Article
• Adherence therapy following acute exacerbation of schizophrenia: A randomised controlled trial in Thailand  Academic Article
• Adherence therapy following an acute episode of schizophrenia: A multi-centre randomised controlled trial  Academic Article
• Adherence therapy for people with schizophrenia  Academic Article
• Adherence therapy for schizophrenia: a randomised controlled trial  Academic Article
• Adherence therapy versus routine psychiatric care for people with schizophrenia spectrum disorders: a randomised controlled trial  Academic Article
• Adherence to Medication and Quality of Life in People With Schizophrenia  Academic Article
• An Investigation of Cardiovascular Risks in a Group of Children and Adolescents Who Use Atypical Antipsychotics  Academic Article
• An RCT of adherence therapy for people with schizophrenia in Chiang Mai, Thailand  Academic Article
• An exploratory, randomized controlled trial of adherence therapy for people with schizophrenia  Academic Article
• Anterior cingulate activation in antipsychotic-naïve first-episode schizophrenia  Academic Article
• Antipsychotic long-acting injections in clinical practice: Medication management and patient choice  Academic Article
• Aripiprazole in schizophrenia: consensus guidelines  Academic Article
• Behavioural and psychological symptoms of dementia and their management in care homes within the East of England: a postal survey  Academic Article
• Borderline Personality Disorder and Mental Healthcare Service Use Among Adolescents  Academic Article
• Cardiometabolic health, prescribed antipsychotics and health-related quality of life in people with schizophrenia-spectrum disorders: a cross-sectional study  Academic Article
• Cash, choice, antipsychotic medication and the mental health nurse  Comment
• Central nervous system medication use in older adults with intellectual disability: Results from the successful ageing in intellectual disability study  Academic Article
• Clinical and Economic Outcomes of Interventions to Reduce Antipsychotic and Benzodiazepine Use Within Nursing Homes: A Systematic Review  Academic Article
• Clozapine reverses schizophrenia-related behaviours in the metabotropic glutamate receptor 5 knockout mouse: association with N-methyl-d-aspartic acid receptor up-regulation  Academic Article
• Cognitive Behavioural Therapy for Auditory Hallucinations: Effectiveness and Predictors of Outcome in a Specialist Clinic  Academic Article
• Commentary on: Hegedüs A. and Kozel B. (2014). Does adherence therapy improve medication adherence among patients with schizophrenia? A systematic review. International Journal of Mental Health Nursing, doi: 10.1111/inm.12089  Academic Article
• Comparing the effect of the subcategories of atypical antipsychotic medications on cognition in schizophrenia using a meta-analytic approach  Academic Article
• Delivering the choice agenda as a framework to manage adverse effects: a mental health nurse perspective on prescribing psychiatric medication  Academic Article
• Determinants of first- and second-generation antipsychotic drug use in clinically unstable patients with schizophrenia treated in four European countries  Academic Article
• Differential Effects of Antipsychotic Drugs on Serotonin-1A Receptor-Mediated Disruption of Prepulse Inhibition  Academic Article
• Do partial agonists cause akathisia: the role of the mental health nurse who prescribes  Academic Article
• Does patient education enhance compliance with clozapine? A preliminary investigation  Academic Article
• Effect of a medication management training package for nurses on clinical outcomes for patients with schizophrenia  Academic Article
• Effectiveness of Adherence Therapy for People With Schizophrenia in Turkey: A Controlled Study  Academic Article
• Effects of chlorpromazine on excitation-contraction coupling events in fast-twitch skeletal muscle fibres of the rat  Academic Article
• Effects of haloperidol and clozapine on sensorimotor gating deficits induced by 5-hydroxytryptamine depletion in the brain  Academic Article
• Effects of motivational interviewing-based adherence therapy for schizophrenia spectrum disorders: A randomized controlled trial  Academic Article
• Enhancing medication adherence in people with schizophrenia: An international programme of research  Academic Article
• Eugenics by the back door? The unintended consequences of restricting people's choices about mental health medicines  Academic Article
• Extended prescribing by UK nurses and pharmacists  Academic Article
• Factors associated with antipsychotic medication adherence in community-based patients with schizophrenia in Hong Kong: A cross sectional study  Academic Article
• From compliance to concordance: a review of the literature on interventions to enhance compliance with antipsychotic medication  Academic Article
• Hippocampal serotonin depletion facilitates the enhancement of prepulse inhibition by risperidone: Possible role of 5-HT2C receptors in the dorsal hippocampus  Academic Article
• In-vivo administration of clozapine affects behaviour but does not reverse dendritic spine deficits in the 14-3-3 zeta KO mouse model of schizophrenia-like disorders  Academic Article
• Interactions of neuroleptic compounds at α2-adrenergic receptor affinity states in bovine caudate nucleus  Academic Article
• Locomotor hyperactivity in 14-3-3ζ KO mice is associated with dopamine transporter dysfunction  Academic Article
• Managing patients with antipsychotic drug-induced hyperprolactinaemia  Academic Article
• Medication Adherence in Schizophrenia: Exploring Patients', Carers' and Professionals' Views  Academic Article
• Medication management for people with a diagnosis of schizophrenia.  Academic Article
• Metabolic Side Effects in Patients Using Atypical Antipsychotic Medications During Hospitalization  Academic Article
• Monitoring of long-term cardiac complications in patients receiving clozapine  Letter
• N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms  Academic Article
• Neuroleptic toxicity syndromes: A clinical spectrum  Academic Article
• Nurse prescribing in mental health: a person-centred approach  Academic Article
• Olanzapine: efficacy in treating the positive and negative symptoms of schizophrenia.  Academic Article
• Partial agonists and schizophrenia: theoretical developments for the development of mental health nursing  Academic Article
• Partial agonists and suicide: the role of the mental health nurse  Academic Article
• Pharmacological management of akathisia in combination with psychological interventions by a mental health nurse consultant  Academic Article
• Phospholipase C-β1 knockout mice exhibit endophenotypes modeling schizophrenia which are rescued by environmental enrichment and clozapine administration  Academic Article
• Practical prescribing with aripiprazole in schizophrenia: consensus recommendations of a UK multidisciplinary panel  Academic Article
• Psychotic illness: Does complementary medicine have a role in management?  Academic Article
• Quetiapine: a new atypical antipsychotic for the treatment of schizophrenia.  Academic Article
• Research in Brief  Academic Article
• Reviewing depot injection efficacy in the treatment of schizophrenia  Academic Article
• Role of serotonin-1A receptors in the action of antipsychotic drugs: comparison of prepulse inhibition studies in mice and rats and relevance for human pharmacology  Academic Article
• Sex-specific transcriptional and proteomic signatures in schizophrenia  Academic Article
• Structure-Activity Relationships for Serotonin Transporter and Dopamine Receptor Selectivity  Academic Article
• Systematic review of patient and nurse attitudes to depot antipsychotic medication  Academic Article
• The Maudsley medication review clinic.  Academic Article
• The development and internal consistency of the Satisfaction with Antipsychotic Medication scale  Academic Article
• The effect of antipsychotic medication on metabolic syndrome  Academic Article
• The effect of the antipsychotic drug quetiapine and its metabolite norquetiapine on acute inflammation, memory and anhedonia  Academic Article
• The effect of λ-type endorphins on α-MSH release in the rat  Academic Article
• The hypothermic response of mice to delta-9-tetrahydrocannabinol is enhanced by chlorpromazine, thioxanthenes, alpha-adrenoceptor antagonists and pentolinium but not by SCH 23390 or sulpiride  Academic Article
• The prevalence of metabolic syndrome amongst patients with severe mental illness in the community in Hong Kong - a cross sectional study  Academic Article
• The use of outcome measures to evaluate the efficacy and tolerability of antipsychotic medication: a comparison of Thorn graduate and CPN practice  Academic Article
• Time to wake up and smell the coffee: antipsychotic medication and schizophrenia  Academic Article
• What can we do about acute extrapyramidal symptoms?  Academic Article
• What is it like to take antipsychotic medication? A qualitative study of patients with first-episode psychosis  Academic Article